Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

PDA Australia Chapter Validation of Sterile Processing and Decontamination Event

Nov 16 - Nov 17, 2017 |
Nov 17, 2017 |
The Victoria Hotel | Melbourne, Australia
  • Chapter
  • Asia-Pacific
Add event to: ICal Outlook Google Calendar

The PDA Australia Chapter is pleased to invite members and non-members to attend our joint industry seminar along with the ISPE Australia Affiliate on the 16th and 17th of November 2017 on Validation of Sterile Processing and Decontamination. The event will take place at The Victoria Hotel, Little Collins Street, Melbourne.

This course will cover essential knowledge, best practice and emerging trends in the validation of manufacturing processes utilised for manufacture of sterile products. Our presenters are internationally recognised as experts in this area. They have extensive experience and their insights and opinions will present attendees with an opportunity to learn first-hand what it really takes to make aseptic process effective and fully compliant with regulatory expectation.

The material presented will provide insight into how regulators and industry are thinking about and approaching aseptic manufacture in the UK and US markets and provide commentary on emerging trends. The presentation style will permit interaction and discussion with the subject matter experts and other present.

It is recommended that participants should be familiar with basic concepts of sterile manufacturing operations prior to attending this course.

About the Speakers

Jeanne Moldenhauer is a senior quality assurance/regulatory affairs professional with extensive background in the development and management of a variety of sterilisation and validation processes in the healthcare industry. She has extensive practical background in both manufacturing facilities and corporate operations. Jeanne has a proven track record of successful NDA, sNDA, ANDA, and DMF submissions to FDA. This has included an extensive background in CMC development for drugs, and special expertise in sterile process validation documentation. She also has extensive background in the rehabilitation of companies with negative FDA findings, restoring them to compliance. Additionally, she has substantial experience in assessing and validating laboratory and production facilities where solutions were needed for regulatory purposes.

She is a Certified Quality Engineer (CQE) and Certified Quality Manager (CQM) (through the American Society for Quality). Jeanne has expertise in utilising information technology to achieve results in quality improvement and cost savings. She is a former Scientific Advisory Board, former Program Advisory Board and former Technical Book Advisory Board member for the Parenteral Drug Association (PDA) and has led Interest Groups for PDA. Jeanne has also served on advisory committees for rapid methods, aseptic processing and sterilisation for FDA. She is a frequent speaker and trainer for a variety of topics within the pharmaceutical and biotechnology industries. She serves on Scientific Advisory Boards for several companies in the area of rapid microbiology.

Richard Denk is working at the company SKAN AG, headquartered in Allschwil in the position Head Sales Containment. Mr. Denk founded 8 years ago the expert Containment group of the ISPE D / A / CH. The Containment Group published the Containment Manual Mr. Denk was responsible for in September 2015. Mr. Denk has spent nearly 20 years with the subject production of highly active / highly hazardous substances and has developed the containment pyramid.

Who should Attend?

  • Quality and validation practitioners, engineers, managers and staff involved in the manufacture of sterile medicinal products
  • Technical professionals, management, vendors and operations personnel who support sterile manufacturing operations.

Take Back to Your Job

  • Understanding of best practice for sterile manufacture and expectations including emerging regulatory views in US and EU.
  • An overview of essential factors underpinning successful sterile manufacturing facilities and operations.
  • An update on current developments in sterile manufacturing generally (including recent ISPE and PDA work in this area). • Understanding of current regulatory focus and concerns of the TGA.


8:45am – 9:15am Registration/Coffee
9:15am Welcome, Introduction and program overview
9:30am – 10:15am Session 1 – Overview of Sterilisation methods
10:15am – 11:00am Session 2 – Validation of Aseptic Filling Processes
11:00am Break
11:15am – 12:00pm Session 3 – Validation of Moist Heat Sterilisation Processes
12:00pm -12:45pm Session 4 – Validation of Gaseous Sterilisation Processes
12:45pm Lunch sponsored by Eurofins AMS Laboratories
1:45pm – 2:45pm Session 5 – Validation of Radiation Sterilisation Processes
2:45pm Break
3:00pm – 4:00pm Session 6 – Validation of Chemical Sterilants
4:00pm – 5:00pm Session 7 – Regulatory Submission of Sterilisation Validation Data
5:00pm – 5:15pm Wrap-up, questions and discussion
5:15pm – 6:15pm Networking drinks and Canapés

8:00am – 8:30am Registration and coffee
8:30am – 8:45am Day one review and Agenda for Day 2
8:45am – 9:30am Session 8 – Introduction on highly potent/toxic or hazardous substances used in the BioTech Industry, Explanation of PDE, OEB and OELs
9:30am – 10:15am Session 9 – Requirements for high potent substances based on occupational hygiene and GMP
10:15am Break
10:30am – 11:15am Session 10 – Aseptic Processing and their requirements for high potent substances for different applications like R&D, ADCs, Highly Potent Bios, Cancer Vaccines, Regenerative medicine.
11:15am – 12:00pm Session 11 – Air handling Unit for aseptic processing & Cycle Development/Decontamination Cycle for H2O2
12:00pm Lunch sponsored by Clean Room Garments
1:00pm – 1:45pm Session 12 – Requirements for high potent aseptic powder processing with different case studies
1:45pm – 2:30pm Session 13 – TBA
2:30pm Break
2:45pm – 3:30pm Session 14 – Cleaning Validation requirements for aseptic processing for non-product contact surfaces
3:30pm – 4:15pm Session 15 - Occupational Hygiene Validation on aseptic filling Isolators
4:15pm – 4:30pm Wrap up, questions and conclusion

NOTE: Schedule times may be varied during the course with the agreement of delegates to ensure content is adequately covered.

Registration and Fees

PDA Member: Early Bird $850 incl GST | Standard $1,050 incl GST
Non member: Early Bird $1,100 incl GST | Standard $1,300 incl GST

Register online with Credit Card via the "Register Now" button above. For cheque & direct deposit payments, please contact David Spaulding or Eoin Hanley for a copy of the Form.

Registration fee includes all day catering and course material (supplied electronically).

Early Bird Rate available until 24 Oct 2017

Register Now